CDKN1B and Bloom syndrome: Prominently, co-treated with BLM, Ad-FIRΔexon2 drastically suppressed Ku86/XRCC5 but increased P27Kip1 expression, and thus enhanced BLM-induced γH2AX expression (Figure 6D, arrows).